824-825 / 2605
‹#›
Patient:
R.R. 14 y.o. female; Stage IIIA nodular sclerosing Hodgkin’s Disease
Dose: 1.8 Gy(RBE) per fraction x 12 to 21.6 Gy(RBE)
Except scatter no dose to breast
tissues by use of posterior field
design
Second Malignancy Induction: Avoidance of Breast Dose with
proton therapy for mediastinal malignancies